Artificial intelligence and machine learning could support drug development for hepatitis A virus internal ribosomal entry sites

2021

Artificial intelligence and machine learning could support drug development for hepatitis A virus internal ribosomal entry sites

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

71

References

0

Citations